📋 Product Overview Table

🌐 Specification	🧾 Details
💊 Active Ingredient	Alendronic Acid 35 mg
🏭 Manufacturer	Cipla Limited
💊 Dosage Form	Oral Tablet
📦 Packaging	4 Tablets in 1 Strip
🩺 Indication	Osteoporosis (especially steroid-induced or postmenopausal)
🇺🇸 US Brand Equivalent	Fosamax (Merck & Co.)
⏱️ Delivery Time	6 to 15 business days

🧬 Introduction – What is Osteofos 35 mg?

Osteofos 35 mg, manufactured by Cipla Limited, is a bisphosphonate medication used primarily to prevent and treat osteoporosis. With its moderate weekly dose of Alendronic Acid, this formulation helps maintain healthy bone mass in adults, particularly postmenopausal women and individuals on long-term corticosteroids.

As a generic equivalent to Fosamax, Osteofos offers high-quality treatment at an affordable price point and is widely accepted in global health systems. It is available for personal import into countries such as the USA, UK, and Australia, making it a reliable choice for international patients.

🎥 Educational Video Overview

📺 “Managing Osteoporosis with Alendronic Acid – Weekly Dosing Explained“
🎬 Video Placeholder – Describes how bisphosphonates strengthen bones and reduce fracture risk.

🎙️ A breakdown of Alendronate’s effects on osteoclast inhibition and calcium metabolism.

🔬 Mechanism of Action – How Alendronate Works

Alendronic Acid works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This leads to improved bone density and reduced risk of vertebral and non-vertebral fractures.

⚗️ Mechanism	🔍 Result
Inhibits bone resorption	Increases bone mineral density
Decreases turnover rate	Promotes skeletal strength
Binds to bone matrix	Provides long-lasting action from weekly doses

💊 Dosage & Administration

📋 Instruction	💊 Details
Weekly Dose	35 mg once a week
Administration Time	Morning, on an empty stomach
With Water Only	Use full glass of plain water only
Post-dose Behavior	Stay upright for 30+ minutes before eating or lying down

Avoid calcium supplements, antacids, or food within 30 minutes after intake.

⚠️ Side Effects & Precautions

💥 Common Reactions	❗ Serious Reactions
Acid reflux, bloating	Esophageal ulceration, bleeding
Headache, constipation	Osteonecrosis of the jaw, rare thigh bone fracture
Muscle pain, joint aches	Severe chest pain or difficulty swallowing

Osteofos should not be used in patients with esophageal abnormalities or those who cannot sit upright.

🧃 Storage Guidelines

Store below 30°C
Keep in dry, original packaging
Away from sunlight and moisture

🌍 Global Availability & Import Guide

🌎 Region	📦 Personal Import Regulations	✅ Prescription Needed
🇺🇸 USA	FDA allows import for personal use with RX	Yes
🇬🇧 UK	MHRA permits under private use clause	Yes
🇦🇺 Australia	TGA authorizes under personal use scheme	Yes

Delivery Time: 6 to 15 business days

🔗 Related Indian Osteoporosis & Bone Supplements

💊 Product	🏭 Manufacturer	📖 Short Description
Bonmax 35 mg	Sun Pharma	Alternative alendronate for weekly osteoporosis therapy
Ostofos Plus	Cipla Ltd	Combination of Alendronate with calcium & vitamin D3
Calcium D3 Max	Cipla Ltd	Bone health supplement with optimal calcium and D3 levels
Ibandronic 150 mg	Natco Pharma	Monthly bisphosphonate used for osteoporosis management
Shelcal HD	Elder Pharma	Calcium + Vitamin D supplement to support bone density

📚 References & External Resources

🩺 Doctor’s Insight – Dr. Rajat Mehra, MD (Endocrinologist)

“Osteofos 35 mg is a well-tolerated option for weekly bisphosphonate therapy in early or moderate osteoporosis. It’s ideal for patients needing a manageable dose with fewer GI side effects.”

⚠️ Disclaimer

This content is for informational use only. Always consult a healthcare provider before beginning any new medication, especially for conditions like osteoporosis.